Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors

Translational Psychiatry

Volumn 5, Issue 3, 2015, Pages

  Garbett, K A ^a   Vereczkei, A ^a,b   Kalman S ^a,c   Wang, L ^a   Korade, Z ^a,d   Shelton, R C ^e   Mirnics, K ^a,c,d  

^a VANDERBILT UNIVERSITY   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE; LIPID; MICRORNA; MICRORNA 199A 3P; MICRORNA 34A; MICRORNA 34B; PROTEIN P53; UNCLASSIFIED DRUG; MESSENGER RNA; TRANSCRIPTOME;

ADULT; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; DSM-IV-TR; ENERGY YIELD; FEMALE; FIBROBLAST; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; LIPID METABOLISM; MAJOR DEPRESSION; MALE; METABOLIC REGULATION; METABOLIC STRESS; UPREGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGICAL STRESS; SKIN; YOUNG ADULT;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; FIBROBLASTS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; RNA, MESSENGER; SKIN; STRESS, PHYSIOLOGICAL; TRANSCRIPTOME; YOUNG ADULT;

EID: 84981194461     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2015.14     Document Type: Article

References (134)

1. Verhoeven JE, Revesz D, Wolkowitz OM, Penninx BW. Cellular aging in depression: permanent imprint or reversible process? An overview of the current evidence, mechanistic pathways, and targets for interventions. Bioessays 2014; 36: 968-978.
2. Klengel T, Binder EB. Gene-environment interactions in major depressive disorder. Can J Psychiatry 2013; 58: 76-83.
3. Mahar I, Bambico FR, Mechawar N, Nobrega JN. Stress serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci Biobehav Rev 2014; 38: 173-192.
4. Yang H, Yang T, Baur JA, Perez E, Matsui T, Carmona JJ et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 2007; 130: 1095-1107.
5. Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G. Mitochondrial control of cellular life, stress, and death. Circ Res 2012; 111: 1198-1207.
6. DiMauro S, Schon EA. Mitochondrial disorders in the nervous system. Annu Rev Neurosci 2008; 31: 91-123.
7. Manji H, Kato T, Di Prospero NA, Ness S, Beal MF, KramS et al. Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 2012; 13: 293-307.
8. Marazziti D, Baroni S, Picchetti M, Landi P, Silvestri S, Vatteroni E et al. Psychiatric disorders and mitochondrial dysfunctions. Eur Rev Med Pharmacol Sci 2012; 16: 270-275.
9. Legido A, Jethva R, Goldenthal MJ. Mitochondrial dysfunction in autism. Semin Pediatr Neurol 2013; 20: 163-175.
10. Tobe EH. Mitochondrial dysfunction, oxidative stress, and major depressive disorder. Neuropsychiatr Dis Treat 2013; 9: 567-573.
11. Gohil VM, Sheth SA, Nilsson R, Wojtovich AP, Lee JH, Perocchi F et al. Nutrientsensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis. Nat Biotechnol 2010; 28: 249-255.
12. Manier DH, Shelton RC, Ellis TC, Peterson CS, Eiring A, Sulser F. Human fibroblasts as a relevant model to study signal transduction in affective disorders. J Affect Disord 2000; 61: 51-58.
13. Wang L, Lockstone HE, Guest PC, Levin Y, Palotas A, Pietsch S et al. Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. J Proteome Res 2010; 9: 521-527.
14. Gasso P, Mas S, Molina O, Lafuente A, Bernardo M, Parellada E. Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naive firstepisode schizophrenia patients. J Psychiatr Res 2014; 48: 94-101.
15. Korade Z, Xu L, Harrison FE, Ahsen R, Hart SE, Folkes OM et al. Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome. Biol Psychiatry 2013; 75: 215-222.
16. Xu L, Korade Z, Rosado DA Jr., Mirnics K, Porter NA. Metabolism of oxysterols derived from nonenzymatic oxidation of 7-dehydrocholesterol in cells. J Lipid Res 2013; 54: 1135-1143.
17. Akin D, Manier DH, Sanders-Bush E, Shelton RC. Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients. Neuropsychopharmacology 2004; 29: 2081-2087.
18. Gibson SA, Korade Z, Shelton RC. Oxidative stress and glutathione response in tissue cultures from persons with major depression. J Psychiatr Res 2012; 46: 1326-1332.
19. Kalman S, Garbett KA, Vereczkei A, Shelton RC, Korade Z, Mirnics K. Metabolic stress-induced microRNA and mRNA expression profiles of human fibroblasts. Exp Cell Res 2013; 320: 343-353.
20. Zhan Y, Yang YT, You HM, Cao D, Liu CY, Zhou CJ et al. Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depression. Eur Psychiatry 2014; 29: 307-315.
21. Karabatsiakis A, Bock C, Salinas-Manrique J, Kolassa S, Calzia E, Dietrich DE et al. Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression. Transl Psychiatry 2014; 4: e397.
22. First MB, Pincus HA. The DSM-IV Text Revision: rationale and potential impact on clinical practice. Psychiatr Serv 2002; 53: 288-292.
23. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264.
24. Kuehn H, Liberzon A, Reich M, Mesirov JP. Using GenePattern for gene expression analysis. Curr Protoc Bioinformatics 2008; Chapter 7: Unit 7.12.
25. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 2007; 23: 3251-3253.
26. Dumortier O, Hinault C, Van Obberghen E. MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metab 2013; 18: 312-324.
27. Jiang P, Du W, Mancuso A, Wellen KE, Yang X. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 2013; 493: 689-693.
28. Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K et al. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis 2010; 31: 2066-2073.
29. Kim S, Lee UJ, Kim MN, Lee EJ, Kim JY, Lee MY et al. MicroRNA miR-199a∗regulates the MET proto-oncogene and the downstream extracellular signalregulated kinase 2 (ERK2). J Biol Chem 2008; 283: 18158-18166.
30. Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, Reddy R, Aschner M, Lewis DA et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 2011; 16: 751-762.
31. Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nat Med 2001; 7: 541-547.
32. Garbett KA, Vereczkei A, Kalman S, Brown JA, Taylor WD, Faludi G et al. Coordinated messenger RNA/MicroRNA changes in fibroblasts of patients with major depression. Biol Psychiatry 2014; 77: 256-265.
33. Baillat D, Hakimi MA, Naar AM, Shilatifard A, Cooch N, Shiekhattar R. Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II. Cell 2005; 123: 265-276.
34. Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 2007; 128: 129-139.
35. Xu K, Chen Z, Qin C, Song X. miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2. Onco Targets Ther 2014; 7: 325-332.
36. Cazanave SC, Mott JL, Elmi NA, Bronk SF, Masuoka HC, Charlton MR et al. A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA. J Lipid Res 2011; 52: 1517-1525.
37. Li S, Meng H, Zhou F, Zhai L, Zhang L, Gu F et al. MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract 2013; 209: 179-183.
38. Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995; 62: 1-9.
39. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999; 85: 275-291.
40. Mamalakis G, Tornaritis M, Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 2002; 67: 311-318.
41. Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003; 13: 267-271.
42. Kaddurah-Daouk R, Bogdanov MB, Wikoff WR, Zhu H, Boyle SH, Churchill E et al. Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo. Transl Psychiatry 2013; 3: e223.
43. Cottrill KA, Chan SY, Loscalzo J. Hypoxamirs and Mitochondrial Metabolism. Antioxid Redox Signal 2013; 21: 1189-1201.
44. Nallamshetty S, Chan SY, Loscalzo J. Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med 2013; 64: 20-30.
45. Liu CR, Miao J, Zhang YL, Liu YM, Yu BG. Effects of hypothyroidism on expression of CRMP2B and ARPC5 during development of the rat frontal cortex. Int J Biol Sci 2013; 9: 209-218.
46. Kobayashi H, Fukuda M. Rab35 regulates Arf6 activity through centaurin-beta2 (ACAP2) during neurite outgrowth. J Cell Sci 2012; 125: 2235-2243.
47. Kahler AK, Djurovic S, Rimol LM, Brown AA, Athanasiu L, Jonsson EG et al. Candidate gene analysis of the human natural killer-1 carbohydrate pathway and perineuronal nets in schizophrenia: B3GAT2 is associated with disease risk and cortical surface area. Biol Psychiatry 2011; 69: 90-96.
48. Liu J, Githinji J, McLaughlin B, Wilczek K, Nolta J. Role of miRNAs in neuronal differentiation from human embryonic stem cell-derived neural stem cells. Stem Cell Rev 2012; 8: 1129-1137.
49. Li B, Sun H. MiR-26a promotes neurite outgrowth by repressing PTEN expression. Mol Med Rep 2013; 8: 676-680.
50. Agostini M, Tucci P, Steinert JR, Shalom-Feuerstein R, Rouleau M, Aberdam D et al. microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci USA 2011; 108: 21099-21104.
51. Khudayberdiev S, Fiore R, Schratt G. MicroRNA as modulators of neuronal responses. Commun Integr Biol 2009; 2: 411-413.
52. Numakawa T, Richards M, Adachi N, Kishi S, Kunugi H, Hashido K. MicroRNA function and neurotrophin BDNF. Neurochem Int 2011; 59: 551-558.
53. Hancock ML, Preitner N, Quan J, Flanagan JG. MicroRNA-132 is enriched in developing axons, locally regulates Rasa1 mRNA, and promotes axon extension. J Neurosci 2014; 34: 66-78.
54. Rodriguez-Aznar E, Barrallo-Gimeno A, Nieto MA. Scratch2 prevents cell cycle reentry by repressing miR-25 in postmitotic primary neurons. J Neurosci 2009; 33: 5095-5105.
55. Aranha MM, Santos DM, Sola S, Steer CJ, Rodrigues CM. miR-34a regulates mouse neural stem cell differentiation. PLoS One 2011; 6: e21396.
56. Yadav S, Pandey A, Shukla A, Talwelkar SS, Kumar A, Pant AB et al. miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2. J Biol Chem 2011; 286: 37347-37357.
57. Jovicic A, Roshan R, Moisoi N, Pradervand S, Moser R, Pillai B et al. Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. J Neurosci 2013; 33: 5127-5137.
58. Pollock A, Bian S, Zhang C, Chen Z, Sun T. Growth of the developing cerebral cortex is controlled by microRNA-7 through the p53 pathway. Cell Rep 2014; 7: 1184-1196.
59. Qi L, Hongjuan H, Ning G, Zhengbin H, Yanjiang X, Tiebo Z et al. miR-370 is stage-specifically expressed during mouse embryonic development and regulates Dnmt3a. FEBS Lett 2013; 587: 775-781.
60. Lin ST, Huang Y, Zhang L, Heng MY, Ptacek LJ, Fu YH. MicroRNA-23a promotes myelination in the central nervous system. Proc Natl Acad Sci USA 2013; 110: 17468-17473.
61. Miller BH, Zeier Z, Xi L, Lanz TA, Deng S, Strathmann J et al. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci USA 2012; 109: 3125-3130.
62. Santarelli DM, Beveridge NJ, Tooney PA, Cairns MJ. Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol Psychiatry 2011; 69: 180-187.
63. Hu YK, Wang X, Li L, Du YH, Ye HT, Li CY. MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1. Neurosci Bull 2013; 29: 745-751.
64. Lai CY, Yu SL, Hsieh MH, Chen CH, Chen HY, Wen CC et al. MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One 2011; 6: e21635.
65. Mor E, Kano S, Colantuoni C, Sawa A, Navon R, Shomron N. MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients. Neurobiol Dis 2013; 55: 1-10.
66. Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne et al. Circulating miRNA biomarkers for Alzheimer's disease. PLoS One 2013; 8: e69807.
67. Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P, Bjorkqvist M. Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum Mol Genet 2011; 20: 2225-2237.
68. Minones-Moyano E, Porta S, Escaramis G, Rabionet R, Iraola S, Kagerbauer B et al. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum Mol Genet 2011; 20: 3067-3078.
69. Zhang R, Zhang Q, Niu J, Lu K, Xie B, Cui D et al. Screening of microRNAs associated with Alzheimer's disease using oxidative stress cell model and different strains of senescence accelerated mice. J Neurol Sci 2014; 338: 57-64.
70. Truettner JS, Katyshev V, Esen-Bilgin N, Dietrich WD, Dore-Duffy P. Hypoxia alters MicroRNA expression in rat cortical pericytes. Microrna 2013; 2: 32-45.
71. Zucchi FC, Yao Y, Ward ID, Ilnytskyy Y, Olson DM, Benzies K et al. Maternal stress induces epigenetic signatures of psychiatric and neurological diseases in the offspring. PLoS One 2013; 8: e56967.
72. Robson JE, Eaton SA, Underhill P, Williams D, Peters J. MicroRNAs 296 and 298 are imprinted and part of the GNAS/Gnas cluster and miR-296 targets IKBKE and Tmed9. RNA 2012; 18: 135-144.
73. Koido K, Eller T, Kingo K, Koks S, Traks T, Shlik J et al. Interleukin 10 family gene polymorphisms are not associated with major depressive disorder and panic disorder phenotypes. J Psychiatr Res 2010; 44: 275-277.
74. Davalos A, Goedeke L, Smibert P, Ramirez CM, Warrier NP, Andreo U et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci USA 2011; 108: 9232-9237.
75. Wang H, Zheng Y, Wang G, Li H. Identification of microRNA and bioinformatics target gene analysis in beef cattle intramuscular fat and subcutaneous fat. Mol Biosyst 2013; 9: 2154-2162.
76. Gao W, He HW, Wang ZM, Zhao H, Lian XQ, Wang YS et al. Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis 2012; 11: 55.
77. Zhang Y, Cheng X, Lu Z, Wang J, Chen H, Fan W et al. Upregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease. Diabetes Res Clin Pract 2013; 99: 327-334.
78. El Azzouzi H, Leptidis S, Dirkx E, Hoeks J, van Bree B, Brand K et al. The hypoxiainducible microRNA cluster miR-199a approximately 214 targets myocardial PPARdelta and impairs mitochondrial fatty acid oxidation. Cell Metab 2013; 18: 341-354.
79. Guo ST, Jiang CC, Wang GP, Li YP, Wang CY, Guo XY et al. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene 2013; 32: 1910-1920.
80. Tekirdag KA, Korkmaz G, Ozturk DG, Agami R, Gozuacik D. MIR181A regulates starvation- and rapamycin-induced autophagy through targeting of ATG5. Autophagy 2013; 9: 374-385.
81. Wei Z, Cui L, Mei Z, Liu M, Zhang D. miR-181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway. FEBS Lett 2014; 588: 1773-1779.
82. Meerson A, Traurig M, Ossowski V, Fleming JM, Mullins M, Baier LJ. Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-alpha. Diabetologia 2013; 56: 1971-1979.
83. Hoffmeister A, Tuennemann J, Sommerer I, Mossner J, Rittger A, Schleinitz D et al. Genetic and biochemical evidence for a functional role of BACE1 in the regulation of insulin mRNA expression. Obesity (Silver Spring) 2013; 21: E626-E633.
84. Collares CV, Evangelista AF, Xavier DJ, Rassi DM, Arns T, Foss-Freitas MC et al. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients. BMC Res Notes 2013; 6: 491.
85. Zehavi L, Avraham R, Barzilai A, Bar-Ilan D, Navon R, Sidi Y et al. Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Mol Cancer 2012; 11: 44.
86. Setyowati Karolina D, Sepramaniam S, Tan HZ, Armugam A, Jeyaseelan K. miR-25 and miR-92a regulate insulin I biosynthesis in rats. RNA Biol 2013; 10: 1365-1378.
87. Latreille M, Hausser J, Stutzer I, Zhang Q, Hastoy B, Gargani S et al. MicroRNA-7a regulates pancreatic beta cell function. J Clin Invest 2014; 124: 2722-2735.
88. Kim HR, Roe JS, Lee JE, Cho EJ, Youn HD. p53 regulates glucose metabolism by miR-34a. Biochem Biophys Res Commun 2013; 437: 225-231.
89. Karbiener M, Pisani DF, Frontini A, Oberreiter LM, Lang E, Vegiopoulos A et al. MicroRNA-26 family is required for human adipogenesis and drives characteristics of brown adipocytes. Stem Cells 2014; 32: 1578-1590.
90. Chen B, Liu Y, Jin X, Lu W, Liu J, Xia Z et al. MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells. BMC Cancer 2014; 14: 443.
91. Gil-Zamorano J, Martin R, Daimiel L, Richardson K, Giordano E, Nicod N et al. Docosahexaenoic acid modulates the enterocyte Caco-2 cell expression of microRNAs involved in lipid metabolism. J Nutr 2014; 144: 575-585.
92. Sangiao-Alvarellos S, Pena-Bello L, Manfredi-Lozano M, Tena-Sempere M, Cordido F. Perturbation of hypothalamic microRNA expression patterns in male rats after metabolic distress: impact of obesity and conditions of negative energy balance. Endocrinology 2014; 155: 1838-1850.
93. Fu T, Seok S, Choi S, Huang Z, Suino-Powell K, Xu HE et al. MiR-34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte FGF21 signaling and SIRT1 function. Mol Cell Biol 2014; 34: 4130-4142.
94. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458: 762-765.
95. Hoffman Y, Bublik DR, Pilpel Y, Oren M. miR-661 downregulates both Mdm2 and Mdm4 to activate p53. Cell Death Differ 2013; 21: 302-309.
96. Wang J, He Q, Han C, Gu H, Jin L, Li Q et al. p53-facilitated miR-199a-3p regulates somatic cell reprogramming. Stem Cells 2012; 30: 1405-1413.
97. Barbagallo D, Piro S, Condorelli AG, Mascali LG, Urbano F, Parrinello N et al. miR-296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic alpha cells to cytokine-induced apoptosis as compared to beta cells. BMC Genomics 2013; 14: 62.
98. Rokavec M, Li H, Jiang L, Hermeking H. The p53/miR-34 axis in development and disease. J Mol Cell Biol 2014; 6: 214-230.
99. Fang L, Zhang HB, Li H, Fu Y, Yang GS. miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90(+) HepG2 cells. Radiol Oncol 2012; 46: 233-241.
100. Seok JK, Lee SH, Kim MJ, Lee YM. MicroRNA-382 induced by HIF-1alpha is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog. Nucleic Acids Res 2014; 42: 8062-8072.
101. Kwon JE, Kim BY, Kwak SY, Bae IH, Han YH. Ionizing radiation-inducible micro- RNA miR-193a-3p induces apoptosis by directly targeting Mcl-1. Apoptosis 2013; 18: 896-909.
102. Tian S, Huang S, Wu S, Guo W, Li J, He X. MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3' untranslated region. Biochem Biophys Res Commun 2010; 396: 435-439.
103. Wu W, Yang J, Feng X, Wang H, Ye S, Yang P et al. MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer 2013; 12: 30.
104. Shi L, Jackstadt R, Siemens H, Li H, Kirchner T, Hermeking H. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer. Cancer Res 2013; 74: 532-542.
105. Song B, Wang Y, Kudo K, Gavin EJ, Xi Y, Ju J. miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res 2008; 14: 8080-8086.
106. Wang F, Yu J, Yang GH, Wang XS, Zhang JW. Regulation of erythroid differentiation by miR-376a and its targets. Cell Res 2011; 21: 1196-1209.
107. Gentilin E, Tagliati F, Filieri C, Mole D, Minoia M, Rosaria Ambrosio et al. miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cdelta. Endocrinology 2013; 154: 1690-1700.
108. Boominathan L. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One 2010; 5: e10615.
109. Khan S, Brougham CL, Ryan J, Sahrudin A, O'Neill G, Wall D et al. miR-379 regulates cyclin B1 expression and is decreased in breast cancer. PLoS One 2013; 8: e68753.
110. Zhong Z, Dong Z, Yang L, Chen X, Gong Z. Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7. Exp Ther Med 2012; 4: 267-272.
111. Zhang S, Zhang C, Li Y, Wang P, Yue Z, Xie S. miR-98 regulates cisplatin-induced A549 cell death by inhibiting TP53 pathway. Biomed Pharmacother 2011; 65: 436-442.
112. Tian Y, Zhang YZ, Chen W. MicroRNA-199a-3p and microRNA-34a regulate apoptosis in human osteosarcoma cells. Biosci Rep 2014; 34: e00132.
113. Cao X, Liu D, Yan X, Zhang Y, Yuan L, Zhang T et al. Stat3 inhibits WTX expression through up-regulation of microRNA-370 in Wilms tumor. FEBS Lett 2013; 587: 639-644.
114. Rahman M, Lovat F, Romano G, Calore F, Acunzo M, Bell EH et al. miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung. J Biol Chem 2014; 289: 26406-26416.
115. Ruan W, Xu JM, Li SB, Yuan LQ, Dai RP. Effects of down-regulation of microRNA-23a on TNF-alpha-induced endothelial cell apoptosis through caspase-dependent pathways. Cardiovasc Res 2011; 93: 623-632.
116. Cirera-Salinas D, Pauta M, Allen RM, Salerno AG, Ramirez CM, Chamorro-Jorganes A et al. Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle 2012; 11: 922-933.
117. Rippo MR, Olivieri F, Monsurro V, Prattichizzo F, Albertini MC, Procopio AD. MitomiRs in human inflamm-aging: a hypothesis involving miR-181a, miR-34a and miR-146a. Exp Gerontol 2014; 56: 154-163.
118. Lee YM, Lee JY, Ho CC, Hong QS, Yu SL, Tzeng CR et al. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. Breast Cancer Res 2011; 13: R116.
119. Reddy SD, Pakala SB, Ohshiro K, Rayala SK, Kumar R. MicroRNA-661 a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions. Cancer Res 2009; 69: 5639-5642.
120. Choudhury Y, Tay FC, Lam DH, Sandanaraj E, Tang C, Ang BT et al. Attenuated adenosine-to-inosine editing of microRNA-376a∗promotes invasiveness of glioblastoma cells. J Clin Invest 2012; 122: 4059-4076.
121. Huang SD, Yuan Y, Zhuang CW, Li BL, Gong DJ, Wang SG et al. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol Cancer 2012; 11: 51.
122. Vaira V, Faversani A, Dohi T, Montorsi M, Augello C, Gatti S et al. miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression. Oncogene 2012; 31: 27-38.
123. Tian Q, Liang L, Ding J, Zha R, Shi H, Wang Q et al. MicroRNA-550a acts as a pro-metastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma. PLoS One 2012; 7: e48958.
124. Jiang DS, Wang YW, Jiang J, Li SM, Liang SZ, Fang HY. MicroRNA-26a involved in Toll-like receptor 9mediated lung cancer growth and migration. Int J Mol Med 2014; 34: 307-312.
125. Liu DZ, Ander BP, Tian Y, Stamova B, Jickling GC, Davis RR et al. Integrated analysis of mRNA and microRNA expression in mature neurons, neural progenitor cells and neuroblastoma cells. Gene 2012; 495: 120-127.
126. Menges CW, Kadariya Y, Altomare D, Talarchek J, Neumann-Domer E, Wu Y et al. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. Cancer Res 2014; 74: 1261-1271.
127. Wang LG, Ni Y, Su BH, Mu XR, Shen HC, Du JJ. MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met. Int J Oncol 2013; 42: 957-962.
128. Niu CS, Yang Y, Cheng CD. MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression. Int J Oncol 2013; 42: 1533-1540.
129. You J, Li Y, Fang N, Liu B, Zu L, Chang R et al. MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2. PLoS One 2014; 9: e91827.
130. Feng S, Pan W, Jin Y, Zheng J. MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2. Tumour Biol 2014; 35: 12339-12344.
131. Wang M, Ren D, Guo W, Wang Z, Huang S, Du H et al. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2. Int J Oncol 2014; 45: 362-372.
132. Li J, Liu X, Qin S, Guan Y, Liu Y, Cheng Y et al. MicroRNA expression profile and functional analysis reveal that miR-382 is a critical novel gene of alcohol addiction. EMBO Mol Med 2013; 5: 1402-1414.
133. Ekdahl Y, Farahani HS, Behm M, Lagergren J, Ohman M. A-to-I editing of microRNAs in the mammalian brain increases during development. Genome Res 2012; 22: 1477-1487.
134. Gaughwin P, Ciesla M, Yang H, Lim B, Brundin P. Stage-specific modulation of cortical neuronal development by Mmu-miR-134. Cereb Cortex 2011; 21: 1857-1869.